Back

Maternal and Neonatal Outcomes in Women with Inflammatory Bowel Disease Following Different Biologic Utilization Trajectories in Pregnancy

2026-01-22 pharmacology and therapeutics Title + abstract only
View on medRxiv
Show abstract

ObjectivesThe 2025 Global Consensus recommends continuing biologics throughout pregnancy in women with inflammatory bowel disease (IBD). Real-world evidence on biologic treatment patterns and outcomes remains limited. This study compared maternal and neonatal outcomes across different biologic use trajectories during pregnancy. MethodsA retrospective study was performed in pregnant women with IBD, treated and/or delivering at the University Hospitals Leuven, Belgium, between 2017 and 2025. Pati...

Predicted journal destinations